Publication | Closed Access
Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial
51
Citations
30
References
2011
Year
These findings support the hypothesis that intracoronary administration of bone marrow-derived, but not peripheral blood-derived CD133 cells 10-14 days after STEMI may improve long-term perfusion.
| Year | Citations | |
|---|---|---|
Page 1
Page 1